Glaucoma decisions — 2025

The Board remands the claims for service connection for a vision disorder, headaches/migraine headaches, a skin condition (claimed as eczema), and bilateral hip pain/bilateral hip disorder to ensure that all necessary development is completed.

The Board denied the Veteran's claim for service connection for an eye disability, including dry eye syndrome, pseudophakia, and glaucoma, finding that there is no evidence linking these conditions to his active duty service or a service-connected condition.

The Board denied service connection for loss of vision/open angle glaucoma/cataracts/choroidal nevus, as the evidence did not support a causal relationship between the Veteran's current eye conditions and his in-service concussion or any other in-service injury.

The Board granted a 50 percent disability evaluation for PTSD, finding the Veteran's symptoms equated to occupational and social impairment with reduced reliability and productivity.

The Board remands the issue of entitlement to service connection for bilateral glaucoma as further development is needed.

The veteran has withdrawn the appeal for service connection of glaucoma.

The Board remands the claim for a secondary service connection analysis of primary open angle glaucoma due to hypertension, specifically requesting an opinion on aggravation.

The Board remands the claim for service connection of glaucoma as secondary to hypertension due to an inadequate VA examination.

The Board remands the claim for an initial rating of service-connected bilateral cataracts and diabetic retinopathy to correct pre-decisional duty-to-assist errors.

The Board remands the claim for a new VA opinion to determine if the Veteran's glaucoma is at least as likely as not due to or aggravated by service-connected diabetes.

The appeal of the proposed reduction in disability rating from 50 percent to 30 percent for migraine headaches is dismissed, and entitlements to an initial compensable rating for mouth and tongue aphthous ulcers, increased rating for left eye old branch retinal artery occlusion with glaucoma, and higher level of special monthly compensation are denied. The service connection claims for gastroesophageal reflux disease (GERD) claimed as acid reflux and sleep apnea are remanded.

The veteran's claim for a compensable rating for hemorrhoids was denied, but the claim for TDIU from December 15, 2020 to September 1, 2022 was granted.

Service connection for glaucoma is granted. The issue of service connection for hypertension is remanded for further evaluation.

The veteran's claim for service connection for prostate cancer and left eye scotoma was denied. An increased disability rating in excess of 10 percent for residuals of retinal scar of the left eye was also denied, but a separate 10 percent disability rating for left eye postoperative cataract was granted. The issue of entitlement to service connection for left eye glaucoma was remanded.

The veteran's PTSD rating was restored to 50% and an increased rating in excess of 70% for PTSD is granted. The claim for glaucoma and its effective date were denied, and the issue of erectile dysfunction was remanded.

The appeal for service connection of bilateral glaucoma is remanded. The VA must provide an examination and medical opinion to determine if the condition is related to military service.

The veteran's claim for a higher rating for glaucoma was denied, but a separate noncompensable rating for visual acuity impairment was granted. The claim for a higher rating for hypertension was also denied. Claims for service connection for dementia and a congenital abnormality were remanded.

The Veteran's claim for service connection for glaucoma was denied. The claim for sleep apnea was remanded for further evaluation.

The veteran was granted a 40% disability rating for diabetic peripheral neuropathy in both legs, but this was later reduced to 10%. The veteran was denied a higher rating for eye conditions and adaptive equipment.

The veteran's claim for service connection for an acquired psychiatric disorder was granted. However, the claims for earlier effective dates for glaucoma with pseudophakia, bilateral hearing loss, and tinnitus were denied.